https://médecine.top/index.php?action=history&feed=atom&title=Tubulopathies
Tubulopathies - Historique des versions
2026-09-02T11:14:17Z
Historique des révisions pour cette page sur le wiki
MediaWiki 1.35.2
https://médecine.top/index.php?title=Tubulopathies&diff=4098&oldid=prev
Julien : /* Nécrose tubulaire aiguë */
2021-10-13T09:43:50Z
<p><span dir="auto"><span class="autocomment">Nécrose tubulaire aiguë</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 13 octobre 2021 à 09:43</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l38" >Ligne 38 :</td>
<td colspan="2" class="diff-lineno">Ligne 38 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Cisplatine</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Cisplatine</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>=== Sédiment <del class="diffchange diffchange-inline">urinaire </del>===</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>=== Sédiment <ins class="diffchange diffchange-inline">et spot urinaires </ins>===</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* <del class="diffchange diffchange-inline">éventuellement </del>légère glucosurie rénale. Pas d’albumine. Pas d’hématies ni de leucocytes. Beaucoup de cylindres granuleux, cylindres de cellules épithéliales.<ref>https://medicalforum.ch/fr/journalfile/view/article/ezm_smf/fr/fms.2001.04295/a25bcaa3c711b150d7230352acd5efd27611c365/fms_2001_04295.pdf/rsrc/jf</ref></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins class="diffchange diffchange-inline">Eventuellement </ins>légère glucosurie rénale. Pas d’albumine. Pas d’hématies ni de leucocytes. Beaucoup de cylindres granuleux, cylindres de cellules épithéliales.<ref>https://medicalforum.ch/fr/journalfile/view/article/ezm_smf/fr/fms.2001.04295/a25bcaa3c711b150d7230352acd5efd27611c365/fms_2001_04295.pdf/rsrc/jf</ref></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">* <u>Spot urinaire:</u> FE<sub>Na</sub> >2%, Na<sub>Urine</sub> > 40 mmol/l ou FE<sub>Urée</sub> >35%</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Obstruction intratubulaire ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Obstruction intratubulaire ==</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=4097&oldid=prev
Julien : /* Définition */
2021-10-13T09:42:22Z
<p><span dir="auto"><span class="autocomment">Définition</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 13 octobre 2021 à 09:42</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l31" >Ligne 31 :</td>
<td colspan="2" class="diff-lineno">Ligne 31 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Définition ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Définition ===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* <u>Types:</u> ischémique, médicamenteuse, rhabdomyolyse</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* <u>Types:</u> ischémique, médicamenteuse, rhabdomyolyse</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">* <u>Caractéristiques:</u> FE<sub>Na</sub> >2%, Na<sub>Urine</sub> > 40 mmol/l ou FE<sub>Urée</sub> >35%</del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Persistance d'une insuffisance rénale > 48−72h, définition arbitraire</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Persistance d'une insuffisance rénale > 48−72h, définition arbitraire</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Entité clinique dont la distinction avec l'insuffisance rénale aiguë d'origine prérénale est discutée<ref>https://www.revmed.ch/RMS/2017/RMS-N-573/Insuffisance-renale-aigue-en-2017-Prise-en-charge-dans-un-hopital-non-universitaire-un-exemple-de-collaboration-interprofessionnelle</ref>.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Entité clinique dont la distinction avec l'insuffisance rénale aiguë d'origine prérénale est discutée<ref>https://www.revmed.ch/RMS/2017/RMS-N-573/Insuffisance-renale-aigue-en-2017-Prise-en-charge-dans-un-hopital-non-universitaire-un-exemple-de-collaboration-interprofessionnelle</ref>.</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=4096&oldid=prev
Julien : /* Définition */
2021-10-13T09:41:38Z
<p><span dir="auto"><span class="autocomment">Définition</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 13 octobre 2021 à 09:41</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l31" >Ligne 31 :</td>
<td colspan="2" class="diff-lineno">Ligne 31 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Définition ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Définition ===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* <u>Types:</u> ischémique, médicamenteuse, rhabdomyolyse</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* <u>Types:</u> ischémique, médicamenteuse, rhabdomyolyse</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* <u>Caractéristiques:</u> FE<sub>Na</sub> >2%, Na<sub>Urine</sub> > 40 mmol/l ou FE<sub>Urée</sub> >35%</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Persistance d'une insuffisance rénale > 48−72h, définition arbitraire</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Persistance d'une insuffisance rénale > 48−72h, définition arbitraire</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Entité clinique dont la distinction avec l'insuffisance rénale aiguë d'origine prérénale est discutée<ref>https://www.revmed.ch/RMS/2017/RMS-N-573/Insuffisance-renale-aigue-en-2017-Prise-en-charge-dans-un-hopital-non-universitaire-un-exemple-de-collaboration-interprofessionnelle</ref>. <del class="diffchange diffchange-inline">Globalement, FE<sub>Na</sub> >2%, Na<sub>Urine</sub> > 40 mmol/l ou FE<sub>Urée</sub> >35%</del></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Entité clinique dont la distinction avec l'insuffisance rénale aiguë d'origine prérénale est discutée<ref>https://www.revmed.ch/RMS/2017/RMS-N-573/Insuffisance-renale-aigue-en-2017-Prise-en-charge-dans-un-hopital-non-universitaire-un-exemple-de-collaboration-interprofessionnelle</ref>.</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Etiologie ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Etiologie ===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Contrast agents are thought to cause acute tubular necrosis through renal vasoconstriction and direct cytotoxicity; however, the mechanisms are not completely understood. Risk factors for CIN include advanced age, diabetic nephropathy, multiple myeloma, concomitant use of nephrotoxins (for example, aminoglycoside antibiotics, NSAIDs), severity of CKD, reduced renal perfusion (due to poor cardiac function or volume depletion), higher dose of contrast, high osmolar contrast (rarely used in industrialized contrast), repeated doses of contrast, and intra-arterial administration. Intravenous isotonic fluids (1-1.5 mL/kg/h 3 to 4 hours before the procedure and continued for 6 to 12 hours) are the mainstay in preventing CIN and perform better than hypotonic fluids.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Contrast agents are thought to cause acute tubular necrosis through renal vasoconstriction and direct cytotoxicity; however, the mechanisms are not completely understood. Risk factors for CIN include advanced age, diabetic nephropathy, multiple myeloma, concomitant use of nephrotoxins (for example, aminoglycoside antibiotics, NSAIDs), severity of CKD, reduced renal perfusion (due to poor cardiac function or volume depletion), higher dose of contrast, high osmolar contrast (rarely used in industrialized contrast), repeated doses of contrast, and intra-arterial administration. Intravenous isotonic fluids (1-1.5 mL/kg/h 3 to 4 hours before the procedure and continued for 6 to 12 hours) are the mainstay in preventing CIN and perform better than hypotonic fluids.</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=3861&oldid=prev
Julien : /* CaractéristiquesCours néphropathies tubulo-interstitielles chroniques CHU Rouen Dre Lise Lelandais, juin 2016 */
2021-08-23T05:29:13Z
<p><span dir="auto"><span class="autocomment">CaractéristiquesCours néphropathies tubulo-interstitielles chroniques CHU Rouen Dre Lise Lelandais, juin 2016</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 23 août 2021 à 05:29</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l3" >Ligne 3 :</td>
<td colspan="2" class="diff-lineno">Ligne 3 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>** <1 g/j</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>** <1 g/j</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>** Protéines de bas poids moléculaire: β2-microglobuline, RBP, chaînes légères d'Ig</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>** Protéines de bas poids moléculaire: β2-microglobuline, RBP, chaînes légères d'Ig</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* ± Leucocyturie <del class="diffchange diffchange-inline">aspetique</del></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* ± Leucocyturie <ins class="diffchange diffchange-inline">aseptique</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* ± Dysfonction tubulaire</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* ± Dysfonction tubulaire</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Hypertension artérielle tardive, au stade 4 et 5 de l'IRC</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Hypertension artérielle tardive, au stade 4 et 5 de l'IRC</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=3860&oldid=prev
Julien : /* Nécrose tubulaire aiguë */
2021-08-23T05:28:30Z
<p><span dir="auto"><span class="autocomment">Nécrose tubulaire aiguë</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 23 août 2021 à 05:28</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l31" >Ligne 31 :</td>
<td colspan="2" class="diff-lineno">Ligne 31 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Définition ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Définition ===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* <u>Types:</u> ischémique, médicamenteuse, rhabdomyolyse</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* <u>Types:</u> ischémique, médicamenteuse, rhabdomyolyse</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Persistance d'une insuffisance rénale > <del class="diffchange diffchange-inline">48-72h</del>, définition arbitraire</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Persistance d'une insuffisance rénale > <ins class="diffchange diffchange-inline">48−72h</ins>, définition arbitraire</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Entité clinique dont la distinction avec l'insuffisance rénale aiguë d'origine prérénale est discutée<ref>https://www.revmed.ch/RMS/2017/RMS-N-573/Insuffisance-renale-aigue-en-2017-Prise-en-charge-dans-un-hopital-non-universitaire-un-exemple-de-collaboration-interprofessionnelle</ref>. Globalement, FE<sub>Na</sub> >2%, Na<sub>Urine</sub> > 40 mmol/l ou FE<sub>Urée</sub> >35%</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Entité clinique dont la distinction avec l'insuffisance rénale aiguë d'origine prérénale est discutée<ref>https://www.revmed.ch/RMS/2017/RMS-N-573/Insuffisance-renale-aigue-en-2017-Prise-en-charge-dans-un-hopital-non-universitaire-un-exemple-de-collaboration-interprofessionnelle</ref>. Globalement, FE<sub>Na</sub> >2%, Na<sub>Urine</sub> > 40 mmol/l ou FE<sub>Urée</sub> >35%</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Etiologie ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Etiologie ===</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=2892&oldid=prev
Julien : /* Néphrites interstitielles */
2020-06-24T17:19:50Z
<p><span dir="auto"><span class="autocomment">Néphrites interstitielles</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 24 juin 2020 à 17:19</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l43" >Ligne 43 :</td>
<td colspan="2" class="diff-lineno">Ligne 43 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Intratubular obstruction can cause AKI through precipitation of either protein or crystals within the tubular lumen. Examples include monoclonal light chain deposition in multiple myeloma, calcium oxalate deposition from ethylene glycol ingestion, crystals from drugs, and uric acid from tumor lysis syndrome</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Intratubular obstruction can cause AKI through precipitation of either protein or crystals within the tubular lumen. Examples include monoclonal light chain deposition in multiple myeloma, calcium oxalate deposition from ethylene glycol ingestion, crystals from drugs, and uric acid from tumor lysis syndrome</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>== <del class="diffchange diffchange-inline">Néphrites interstitielles </del>==</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== <ins class="diffchange diffchange-inline">Néphrite interstitielle </ins>==</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">* Triade classique: fièvre, rash cutané et éosinophilie</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Néphrologie]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Néphrologie]]</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=2883&oldid=prev
Julien : /* Acidose tubulaire rénale distale de type 4 */
2020-06-24T07:27:40Z
<p><span dir="auto"><span class="autocomment">Acidose tubulaire rénale distale de type 4</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 24 juin 2020 à 07:27</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l23" >Ligne 23 :</td>
<td colspan="2" class="diff-lineno">Ligne 23 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Défaut d'ammoniogenèse'''</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Défaut d'ammoniogenèse'''</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* In type 4 (hyperkalemic distal) renal tubular acidosis, aldosterone deficiency or resistance causes hyperkalemia and decreased NH<sub>4</sub><sup>+</sup> excretion; treatment includes correction of the underlying cause and treatment of hyperkalemia.<ref name="mksap" /></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* In type 4 (hyperkalemic distal) renal tubular acidosis, aldosterone deficiency or resistance causes hyperkalemia and decreased NH<sub>4</sub><sup>+</sup> excretion; treatment includes correction of the underlying cause and treatment of hyperkalemia.<ref name="mksap" /></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Hypoaldostéronisme associé → Hyperkaliémie</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins class="diffchange diffchange-inline">[[Fonction_surrénalienne#Hypoaldost.C3.A9ronisme|</ins>Hypoaldostéronisme<ins class="diffchange diffchange-inline">]] </ins>associé → Hyperkaliémie</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Syndrome de Fanconi ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Syndrome de Fanconi ==</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=2879&oldid=prev
Julien le 24 juin 2020 à 06:29
2020-06-24T06:29:32Z
<p></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 24 juin 2020 à 06:29</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l42" >Ligne 42 :</td>
<td colspan="2" class="diff-lineno">Ligne 42 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Obstruction intratubulaire ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Obstruction intratubulaire ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Intratubular obstruction can cause AKI through precipitation of either protein or crystals within the tubular lumen. Examples include monoclonal light chain deposition in multiple myeloma, calcium oxalate deposition from ethylene glycol ingestion, crystals from drugs, and uric acid from tumor lysis syndrome</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Intratubular obstruction can cause AKI through precipitation of either protein or crystals within the tubular lumen. Examples include monoclonal light chain deposition in multiple myeloma, calcium oxalate deposition from ethylene glycol ingestion, crystals from drugs, and uric acid from tumor lysis syndrome</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Néphrites interstitielles ==</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Néphrologie]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Néphrologie]]</div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=2700&oldid=prev
Julien : /* Etiologie */
2020-06-18T08:57:19Z
<p><span dir="auto"><span class="autocomment">Etiologie</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 18 juin 2020 à 08:57</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l35" >Ligne 35 :</td>
<td colspan="2" class="diff-lineno">Ligne 35 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Etiologie ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Etiologie ===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Contrast agents are thought to cause acute tubular necrosis through renal vasoconstriction and direct cytotoxicity; however, the mechanisms are not completely understood. Risk factors for CIN include advanced age, diabetic nephropathy, multiple myeloma, concomitant use of nephrotoxins (for example, aminoglycoside antibiotics, NSAIDs), severity of CKD, reduced renal perfusion (due to poor cardiac function or volume depletion), higher dose of contrast, high osmolar contrast (rarely used in industrialized contrast), repeated doses of contrast, and intra-arterial administration. Intravenous isotonic fluids (1-1.5 mL/kg/h 3 to 4 hours before the procedure and continued for 6 to 12 hours) are the mainstay in preventing CIN and perform better than hypotonic fluids.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Contrast agents are thought to cause acute tubular necrosis through renal vasoconstriction and direct cytotoxicity; however, the mechanisms are not completely understood. Risk factors for CIN include advanced age, diabetic nephropathy, multiple myeloma, concomitant use of nephrotoxins (for example, aminoglycoside antibiotics, NSAIDs), severity of CKD, reduced renal perfusion (due to poor cardiac function or volume depletion), higher dose of contrast, high osmolar contrast (rarely used in industrialized contrast), repeated doses of contrast, and intra-arterial administration. Intravenous isotonic fluids (1-1.5 mL/kg/h 3 to 4 hours before the procedure and continued for 6 to 12 hours) are the mainstay in preventing CIN and perform better than hypotonic fluids.</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* Cisplatine</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Sédiment urinaire ===</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>=== Sédiment urinaire ===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* éventuellement légère glucosurie rénale. Pas d’albumine. Pas d’hématies ni de leucocytes. Beaucoup de cylindres granuleux, cylindres de cellules épithéliales.<ref>https://medicalforum.ch/fr/journalfile/view/article/ezm_smf/fr/fms.2001.04295/a25bcaa3c711b150d7230352acd5efd27611c365/fms_2001_04295.pdf/rsrc/jf</ref></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* éventuellement légère glucosurie rénale. Pas d’albumine. Pas d’hématies ni de leucocytes. Beaucoup de cylindres granuleux, cylindres de cellules épithéliales.<ref>https://medicalforum.ch/fr/journalfile/view/article/ezm_smf/fr/fms.2001.04295/a25bcaa3c711b150d7230352acd5efd27611c365/fms_2001_04295.pdf/rsrc/jf</ref></div></td></tr>
</table>
Julien
https://médecine.top/index.php?title=Tubulopathies&diff=2433&oldid=prev
Julien : /* Obstruction tubulaire */
2020-06-10T12:35:48Z
<p><span dir="auto"><span class="autocomment">Obstruction tubulaire</span></span></p>
<table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="fr">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Version précédente</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version du 10 juin 2020 à 12:35</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l38" >Ligne 38 :</td>
<td colspan="2" class="diff-lineno">Ligne 38 :</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* éventuellement légère glucosurie rénale. Pas d’albumine. Pas d’hématies ni de leucocytes. Beaucoup de cylindres granuleux, cylindres de cellules épithéliales.<ref>https://medicalforum.ch/fr/journalfile/view/article/ezm_smf/fr/fms.2001.04295/a25bcaa3c711b150d7230352acd5efd27611c365/fms_2001_04295.pdf/rsrc/jf</ref></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* éventuellement légère glucosurie rénale. Pas d’albumine. Pas d’hématies ni de leucocytes. Beaucoup de cylindres granuleux, cylindres de cellules épithéliales.<ref>https://medicalforum.ch/fr/journalfile/view/article/ezm_smf/fr/fms.2001.04295/a25bcaa3c711b150d7230352acd5efd27611c365/fms_2001_04295.pdf/rsrc/jf</ref></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>== Obstruction <del class="diffchange diffchange-inline">tubulaire </del>==</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== Obstruction <ins class="diffchange diffchange-inline">intratubulaire </ins>==</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Intratubular obstruction can cause AKI through precipitation of either protein or crystals within the tubular lumen. Examples include monoclonal light chain deposition in multiple myeloma, calcium oxalate deposition from ethylene glycol ingestion, crystals from drugs, and uric acid from tumor lysis syndrome</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Références ==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Néphrologie]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Néphrologie]]</div></td></tr>
</table>
Julien